These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 26348403

  • 1. Conformationally selective biophysical assay for influenza vaccine potency determination.
    Wen Y, Han L, Palladino G, Ferrari A, Xie Y, Carfi A, Dormitzer PR, Settembre EC.
    Vaccine; 2015 Oct 05; 33(41):5342-5349. PubMed ID: 26348403
    [Abstract] [Full Text] [Related]

  • 2. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y, Palladino G, Xie Y, Ferrari A, Ma X, Han L, Dormitzer PR, Settembre EC.
    Vaccine; 2016 Jun 17; 34(29):3388-95. PubMed ID: 27154389
    [Abstract] [Full Text] [Related]

  • 3. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Wen Y, Palladino G, Xie Y, Ferrari A, Settembre EC.
    Vaccine; 2018 May 17; 36(21):3010-3017. PubMed ID: 29680201
    [Abstract] [Full Text] [Related]

  • 4. Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay.
    Lorbetskie B, Cunningham AM, Lemieux M, Durno L, Farnsworth A, Wang J, Li C, Li X, Gilbert M, Sauvé S, Girard M.
    Anal Chem; 2019 Jul 16; 91(14):8908-8917. PubMed ID: 31251585
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A hemagglutinin quantification method for development of an influenza pandemic vaccine using size exclusion high performance liquid chromatography.
    Roh HS, Song HM, Yun BR, Kang HK, Choi KS, Park YJ, Kim DS, Kim SH, Mo IP, An BS, Ahn CY.
    Mol Med Rep; 2015 Apr 16; 11(4):2819-24. PubMed ID: 25482872
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR, Byrne-Nash R, Gillis J, Bueter K, Couzens LK, Eichelberger MC, Rowlen KL.
    Vaccine; 2018 May 17; 36(21):2937-2945. PubMed ID: 29699789
    [Abstract] [Full Text] [Related]

  • 14. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.
    Khurana S, King LR, Manischewitz J, Coyle EM, Golding H.
    Vaccine; 2014 Apr 17; 32(19):2188-97. PubMed ID: 24613520
    [Abstract] [Full Text] [Related]

  • 15. N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing.
    An Y, Parsons LM, Jankowska E, Melnyk D, Joshi M, Cipollo JF.
    J Virol; 2019 Jan 15; 93(2):. PubMed ID: 30355697
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
    Legastelois I, Chevalier M, Bernard MC, de Montfort A, Fouque M, Pilloud A, Serraille C, Devard N, Engel O, Sodoyer R, Moste C.
    J Virol Methods; 2011 Dec 15; 178(1-2):129-36. PubMed ID: 21907241
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.